539 related articles for article (PubMed ID: 32034657)
1. Comparison of Traumatic Intracranial Hemorrhage Expansion and Outcomes Among Patients on Direct Oral Anticoagulants Versus Vitamin k Antagonists.
Shin SS; Marsh EB; Ali H; Nyquist PA; Hanley DF; Ziai WC
Neurocrit Care; 2020 Apr; 32(2):407-418. PubMed ID: 32034657
[TBL] [Abstract][Full Text] [Related]
2. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
Adachi T; Hoshino H; Takagi M; Fujioka S;
Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
[TBL] [Abstract][Full Text] [Related]
3. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants.
Ashley J; McArthur E; Bota S; Harel Z; Battistella M; Molnar AO; Jun M; Badve SV; Garg AX; Manuel D; Tanuseputro P; Wells P; Mavrakanas T; Rhodes E; Sood MM
Am J Kidney Dis; 2020 Sep; 76(3):311-320. PubMed ID: 32333946
[TBL] [Abstract][Full Text] [Related]
4. Low Risk of Traumatic Intracranial Hematoma Expansion with Factor Xa Inhibitors without Andexanet Reversal.
Maragkos GA; Nelton EB; Richter S; Stippler M
World Neurosurg; 2020 Oct; 142():e95-e100. PubMed ID: 32561488
[TBL] [Abstract][Full Text] [Related]
5. Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.
Boulouis G; Morotti A; Pasi M; Goldstein JN; Gurol ME; Charidimou A
J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):263-270. PubMed ID: 29030422
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and Bayesian network meta-analysis of risk of intracranial hemorrhage with direct oral anticoagulants.
Wolfe Z; Khan SU; Nasir F; Raghu Subramanian C; Lash B
J Thromb Haemost; 2018 Jul; 16(7):1296-1306. PubMed ID: 29723935
[TBL] [Abstract][Full Text] [Related]
7. Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants.
Ording AG; Søgaard M; Skjøth F; Grove EL; Lip GYH; Larsen TB; Nielsen PB
Cancer Med; 2021 Jul; 10(13):4405-4414. PubMed ID: 34114733
[TBL] [Abstract][Full Text] [Related]
8. [Management of bleeding associated with direct oral anticoagulants: update on reversal strategies].
Enríquez A; Baranchuk A; Corbalán R
Rev Med Chil; 2019; 147(1):73-82. PubMed ID: 30848768
[TBL] [Abstract][Full Text] [Related]
9. The novel oral anticoagulants (NOACs) have worse outcomes compared with warfarin in patients with intracranial hemorrhage after TBI.
Zeeshan M; Jehan F; O'Keeffe T; Khan M; Zakaria ER; Hamidi M; Gries L; Kulvatunyou N; Joseph B
J Trauma Acute Care Surg; 2018 Nov; 85(5):915-920. PubMed ID: 29851905
[TBL] [Abstract][Full Text] [Related]
10. Risk of Intracranial Hemorrhage in Ground-level Fall With Antiplatelet or Anticoagulant Agents.
Ganetsky M; Lopez G; Coreanu T; Novack V; Horng S; Shapiro NI; Bauer KA
Acad Emerg Med; 2017 Oct; 24(10):1258-1266. PubMed ID: 28475282
[TBL] [Abstract][Full Text] [Related]
11. [Monitoring options and reversal agents for oral anticoagulants].
Thorup SB; Husted SE; Vang ML
Ugeskr Laeger; 2014 Apr; 176(9):. PubMed ID: 25096568
[TBL] [Abstract][Full Text] [Related]
12. Direct oral anticoagulant- versus vitamin K antagonist-related gastrointestinal bleeding: Insights from a nationwide cohort.
Butt JH; Li A; Xian Y; Peterson ED; Garcia D; Torp-Pedersen C; Køber L; Fosbøl EL
Am Heart J; 2019 Oct; 216():117-124. PubMed ID: 31425898
[TBL] [Abstract][Full Text] [Related]
13. Management of Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents.
Ruff CT; Giugliano RP; Antman EM
Circulation; 2016 Jul; 134(3):248-61. PubMed ID: 27436881
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Symptomatic Intracerebral Hemorrhage in Patient Receiving Direct Oral Anticoagulants: Comparison with Warfarin.
Kawabori M; Niiya Y; Iwasaki M; Mabuchi S; Ozaki H; Matsubara K; Houkin K
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1338-1342. PubMed ID: 29397310
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.
Kanai Y; Oguro H; Tahara N; Matsuda H; Takayoshi H; Mitaki S; Onoda K; Yamaguchi S
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):338-345. PubMed ID: 29033229
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Efficacy and Safety of Direct Oral Anticoagulants in Japanese Patients-Analysis of Pharmaceuticals and Medical Devices Agency Data.
Terayama Y
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1171-1181. PubMed ID: 28169097
[TBL] [Abstract][Full Text] [Related]
18. Treatment and outcomes of anticoagulated geriatric trauma patients with traumatic intracranial hemorrhage after falls.
Nederpelt CJ; Naar L; Meier K; van Wijck SFM; Krijnen P; Velmahos GC; Kaafarani HMA; Rosenthal MG; Schipper IB
Eur J Trauma Emerg Surg; 2022 Oct; 48(5):4297-4304. PubMed ID: 35267051
[TBL] [Abstract][Full Text] [Related]
19. Acute subdural hematoma in patients on oral anticoagulant therapy: management and outcome.
Won SY; Dubinski D; Bruder M; Cattani A; Seifert V; Konczalla J
Neurosurg Focus; 2017 Nov; 43(5):E12. PubMed ID: 29088960
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
Yao X; Abraham NS; Sangaralingham LR; Bellolio MF; McBane RD; Shah ND; Noseworthy PA
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
